A Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice
NCT06748456 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2024-12-27
Summary
It is widely acknowledged that prostate specific antigen (PSA) testing can lead to false-positives, overdiagnosis and overtreatment of prostate cancer. The current national clinical guidelines only recommend the test to a small group of patients and does not recommend neither systematic nor opportunistic screening for prostate cancer with the test.
The aim of this cluster randomized trial is to evaluate the effectiveness of a complex intervention aimed at improving the use of evidence based practice when using prostate specific antigen tests in general practice.
The complex intervention in this study is a so called cluster package which is meeting material to a quality cluster meeting as almost every general practitioner is a member of a quality cluster. Therefore, the investigators have developed a cluster package aimed at promoting an evidence-based use of the prostate specific antigen test to general practitioners.
Conditions
- Prostate Cancer
- Evidence Based Medicine
- Prostate Specific Antigen
Interventions
- BEHAVIORAL
-
Podcast
A pre-recorded podcast with a urologist and a GP discussing the theme to promote preparatory reflections among the GPs before the cluster meeting
- BEHAVIORAL
-
Cluster meeting
A two-hour meeting facilitated by either the GPs cluster coordinator, another GP from the cluster or a facilitator outside the cluster chosen by the cluster itself with specific slides about PSA in general, guidelines, expert videos, data from the clinics, cases, and group discussions
- BEHAVIORAL
-
Hand-out material 1
Hand-outs of the main take-home messages to facilitate further discussion in their respective GP offices
- BEHAVIORAL
-
Hand-out material 2
Hand-outs to be used by GP and patients to facilitate communication about the relevance of taking a PSA-test
Sponsors & Collaborators
-
Kvalitet i Almen Praksis (KiAP)
collaborator UNKNOWN -
University of Copenhagen
lead OTHER
Principal Investigators
-
Marius Brostrøm Kousgaard, Associate professor · Center of General Practice, Department of Public Health, University of Copenhagen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-09
- Primary Completion
- 2026-01-01
- Completion
- 2026-01-01
Countries
- Denmark
Study Locations
More Related Trials
-
Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)
NCT00840294 ·Status: TERMINATED ·Phase: PHASE3
-
Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasia
NCT00780754 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS)
NCT01250483 ·Status: COMPLETED
-
Dietary Intervention With Phytochemicals and Polyunsaturated Fatty Acids in Prostate Cancer Patients
NCT00433797 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Pilot Study of Prostate Cancer-specific Anxiety in Active Surveillance
NCT03227744 ·Status: TERMINATED ·Phase: NA
-
Facilitating Shared Decisionmaking About Prostate Cancer Screening
NCT00013247 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
NCT04947631 ·Status: COMPLETED ·Phase: PHASE3
-
PRescription Exercise for Older Men With Urinary Disease
NCT06225479 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
NCT02167919 ·Status: COMPLETED ·Phase: NA
-
Clinical Utility Study for MyProstateScore+
NCT05525806 ·Status: COMPLETED ·Phase: NA
-
The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage
NCT01484808 ·Status: UNKNOWN
-
Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence
NCT01390870 ·Status: COMPLETED
-
Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction
NCT00827814 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Median Lobe Prostatic UroLift Procedure
NCT02625545 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effects of a Prostate Health Formulation
NCT02886832 ·Status: COMPLETED ·Phase: NA
-
Sulphate Accumulation in Prostate
NCT02821728 ·Status: COMPLETED ·Phase: NA
-
Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
NCT03297398 ·Status: TERMINATED ·Phase: PHASE2
-
Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer
NCT00985738 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy
NCT00866554 ·Status: COMPLETED ·Phase: PHASE2
-
The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia
NCT00687388 ·Status: WITHDRAWN ·Phase: PHASE4
-
Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer Surgery
NCT00335634 ·Status: COMPLETED
-
PSA Glycomics Assay for Early Detection of Prostate Cancer
NCT04393376 ·Status: UNKNOWN ·Phase: NA
-
Impact of Antibiotic Treatment on Prostate-Specific Antigen (PSA) Variability
NCT00596453 ·Status: TERMINATED ·Phase: PHASE4
-
Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy
NCT00201630 ·Status: UNKNOWN ·Phase: PHASE3
-
Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years
NCT02757963 ·Status: COMPLETED ·Phase: PHASE4